| A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial (NCT05205837) | Rigshospitalet, Denmark | 2021-11-24 |
| A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel (NCT04976595) | Acerus Pharmaceuticals Corporation | 2021-07-01 |
| The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population (NCT06247267) | Walter Reed National Military Medical Center | 2021-03-09 |
| Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury (NCT04460872) | North Florida Foundation for Research and Education | 2021-01-31 |
| Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone (NCT04731376) | Emory University | 2021-01-25 |
| Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs (NCT04630275) | Lars Møller Pedersen | 2020-12-01 |
| A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism (NCT04456296) | Endo USA Inc., a Keenova Therapeutics Company | 2020-06-30 |
| A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants (NCT04320745) | Allergan | 2020-05-19 |
| A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism (NCT04274894) | AbbVie | 2020-05-12 |
| Testopel ® vs. Generic Testosterone Pellets. (NCT04523480) | University of Miami | 2020-03-12 |
| Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism (NCT03887936) | VA Office of Research and Development | 2019-10-01 |
| A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males (NCT03792477) | Pfizer | 2019-01-19 |
| Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men. (NCT03281187) | FBM Industria Brasileira Ltda | 2018-07-16 |
| Hypothalamic-pituitary Dysfunction in Diabetes (NCT05752591) | Istituto Auxologico Italiano | 2018-05-25 |
| A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men (NCT03518034) | AbbVie | 2018-05-03 |
| Evaluation of Testosterone Nasal Gel in Hypogonadal Boys (NCT03345797) | Acerus Biopharma Inc. | 2018-03-01 |
| Extragonadal Effects of hCG on Calcium Homeostasis (NCT03418896) | Martin Blomberg Jensen | 2018-01-06 |
| Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus (NCT03437109) | Besins Healthcare | 2017-12-06 |
| Administration of Kisspeptin in Patients With Hyperprolactinemia (NCT02956447) | Massachusetts General Hospital | 2017-11-17 |
| A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males (NCT03335254) | TesoRx Pharma, LLC | 2017-11-06 |
| Long-term Lifestyle Change and Testosterone Replacement (NCT03256292) | Baylor College of Medicine | 2017-08-21 |
| Testosterone Plus Finasteride Treatment After Spinal Cord Injury (NCT02248701) | VA Office of Research and Development | 2017-04-27 |
| Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ (NCT02937740) | Acerus Pharmaceuticals Corporation | 2016-10-01 |
| The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate (NCT02921386) | Clarus Therapeutics, Inc. | 2016-10-01 |
| Effects of Testosterone on Myocardial Repolarization (NCT03126656) | University of Roma La Sapienza | 2016-09-01 |
| Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction (NCT02803073) | Texas Tech University Health Sciences Center | 2016-08-01 |
| Cardiovascular Outcomes of Low Testosterone (NCT02758431) | University of Colorado, Denver | 2016-07-01 |
| Testosterone Replacement in Renal Failure (NCT02712944) | Texas Tech University Health Sciences Center | 2016-07-01 |
| Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism (NCT02777242) | Antares Pharma Inc. | 2016-06-01 |
| Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot) (NCT02959853) | Baylor College of Medicine | 2016-06-01 |
| Association Between Testosterone Levels and COPD Severity (NCT02824809) | Hospital Italiano de Buenos Aires | 2016-06-01 |
| A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men (NCT02722278) | Clarus Therapeutics, Inc. | 2016-03-01 |
| Phlebotomy Study of Testosterone Undecanoate (NCT02670343) | Clarus Therapeutics, Inc. | 2016-01-01 |
| Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome (NCT02672592) | University Hospital, Basel, Switzerland | 2016-01-01 |
| Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors (NCT02419105) | University of Zurich | 2015-09-01 |
| Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism (NCT02137265) | University of Illinois at Chicago | 2015-09-01 |
| Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (NCT02504541) | Antares Pharma Inc. | 2015-07-01 |
| Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDS (NCT03057899) | Pusan National University Hospital | 2015-06-01 |
| Testosterone Therapy in Hypogonadal Men Treated With Opioids (NCT02433730) | Marianne Andersen | 2015-05-01 |
| Psychological Outcomes in Isolated GnRH Deficiency (NCT02356172) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2015-02-04 |
| Hormonal Predictors of Oncologic Surgery (NCT02471157) | Weill Medical College of Cornell University | 2015-01-01 |
| Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism. (NCT03619330) | University Medical Centre Ljubljana | 2014-12-01 |
| Pharmacokinetic Study of Subcutaneous Testosterone Enanthate (NCT02233751) | Antares Pharma Inc. | 2014-09-01 |
| Oral Testosterone for the Treatment of Hypogonadism in Males (NCT02222558) | TesoRx Pharma, LLC | 2014-09-01 |
| Evaluation of Furosap in Human Volunteers (NCT02748005) | Chemical Resources | 2014-08-01 |
| Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism (NCT02159469) | Antares Pharma Inc. | 2014-07-01 |
| MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism (NCT02102646) | Herlev Hospital | 2014-04-01 |
| Androgen Regulation of Priapism in Sickle Cell Disease (NCT01940718) | Johns Hopkins University | 2014-03-01 |
| An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men (NCT02082197) | AbbVie | 2014-03-01 |
| The Efficacy Study of FUROSAP: A Testosterone Booster Supplement In Humans. (NCT02702882) | Chemical Resources | 2014-02-01 |
| Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism (NCT01084369) | Tameside Hospital NHS Foundation Trust | 2013-10-11 |
| Pharmacokinetic Study of Testosterone Enanthate (NCT01887418) | Antares Pharma Inc. | 2013-09-01 |
| Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration (NCT01880086) | Weill Medical College of Cornell University | 2013-08-01 |
| Testosterone, Metformin, or Both, for Hypogonadism in Obese Males (NCT02514629) | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2013-07-04 |
| Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment (NCT02111434) | Gulhane School of Medicine | 2013-07-01 |
| The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel (NCT01893281) | Eli Lilly and Company | 2013-07-01 |
| Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) (NCT01919294) | Sheffield Teaching Hospitals NHS Foundation Trust | 2013-07-01 |
| Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients (NCT02248467) | University of Florence | 2013-05-01 |
| A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy (NCT01816295) | Eli Lilly and Company | 2013-05-01 |
| A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) (NCT01709331) | Organon and Co | 2013-02-11 |
| Testosterone Undecanoate and Quality of Life of Men and Spouses (NCT01758029) | Meir Medical Center | 2013-01-01 |
| Study of the Prevalence and Associated Factors With Hypogonadism in HIV + Men (NCT02665559) | Tourcoing Hospital | 2013-01-01 |
| Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism (NCT01786473) | Laboratoires Besins International | 2012-12-01 |
| Vitamin D Treatment and Hypogonadism in Men (NCT01748370) | Medical University of Graz | 2012-12-01 |
| TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST (NCT02366975) | University of Florence | 2012-11-01 |
| Oral Testosterone for the Treatment of Hypogonadism (NCT01717768) | TesoRx Pharma, LLC | 2012-10-01 |
| Testosterone and Pain Sensitivity (NCT01689896) | Johns Hopkins University | 2012-08-01 |
| Hormonal Regulation of Puberty and Fertility (NCT01511588) | National Institute of Environmental Health Sciences (NIEHS) | 2012-04-25 |
| Inherited Reproductive Disorders (NCT01500447) | National Institute of Environmental Health Sciences (NIEHS) | 2012-04-25 |
| Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation (NCT02434562) | Universitaire Ziekenhuizen KU Leuven | 2012-04-01 |
| Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) (NCT01560546) | Marianne Andersen | 2012-03-01 |
| CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy (NCT01378299) | VA Office of Research and Development | 2011-10-01 |
| Testosterone and Alendronate in Hypogonadal Men (NCT01460654) | Massachusetts General Hospital | 2011-10-01 |
| A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels (NCT01419236) | Eli Lilly and Company | 2011-08-01 |
| Testosterone Therapy in Heart Failure (NCT01377103) | Cedars-Sinai Medical Center | 2011-07-01 |
| A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 (NCT01386567) | Repros Therapeutics Inc. | 2011-07-01 |
| Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems (NCT01323140) | Watson Pharmaceuticals | 2011-04-01 |
| NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH) (NCT01092858) | Bayer | 2010-09-01 |
| A Study to Evaluate the Potential for Interpersonal Transfer of Testosterone Following Single Dose Application (NCT01172366) | Acrux DDS Pty Ltd | 2010-08-01 |
| Quality of Life With TESTIM® (NCT01148433) | Ferring Pharmaceuticals | 2010-05-01 |
| Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males (NCT01133548) | AbbVie | 2010-05-01 |
| Testosterone Replacement in Men With Diabetes and Obesity (NCT01127659) | University at Buffalo | 2010-05-01 |
| Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men (NCT01104246) | Watson Pharmaceuticals | 2010-04-01 |
| Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure (NCT00998933) | Solvay Pharmaceuticals | 2009-10-01 |
| Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes (NCT00440440) | Diabetes Center of the Southwest | 2009-08-01 |
| Efficacy and Tolerability of an Intra-Nasal Testosterone Product (NCT00975650) | Acerus Pharmaceuticals Corporation | 2009-08-01 |
| Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism (NCT01160341) | Gulhane School of Medicine | 2009-08-01 |
| The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism (NCT02111473) | Gulhane School of Medicine | 2009-05-01 |
| To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion (NCT00857168) | Acrux DDS Pty Ltd | 2009-01-01 |
| Reandron in Diabetic Men Witn Low Testosterone Level (NCT00613782) | Austin Health | 2009-01-01 |
| Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism (NCT00837616) | Nemours Children's Clinic | 2009-01-01 |
| Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen (NCT04545450) | Unita Complessa di Ostetricia e Ginecologia | 2008-11-04 |
| A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations (NCT00857454) | Eli Lilly and Company | 2008-10-01 |
| ORAL T-6: Oral Androgens in Man-6 (NCT00663793) | University of Washington | 2008-10-01 |
| Androgen Deprivation Therapy Study (NCT00743327) | National Institute on Aging (NIA) | 2008-10-01 |
| Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks (NCT00710827) | Bayer | 2008-10-01 |
| Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement (NCT00752869) | The Miriam Hospital | 2008-09-01 |
| A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations (NCT00702650) | Eli Lilly and Company | 2008-06-01 |
| Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men (NCT00695110) | Clarus Therapeutics, Inc. | 2008-06-01 |
| NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers (NCT00647868) | Acerus Pharmaceuticals Corporation | 2008-05-01 |